Latest Cancer treatments Stories
TUEBINGEN, Germany, July 16, 2014 /PRNewswire/ -- Funds will be used to complete phase 3 study with IMA901 and to invest in the expansion of immatics' Human Immunopeptidome
This collaboration complements world-class cancer care with sophisticated scientific research focused on providing targeted therapies DANVILLE, Pa.
TORONTO, July 15, 2014 /CNW/ - The Odette Cancer Centre at Sunnybrook Health Sciences Centre in conjunction with Galderma Canada are pleased to announce that Metvix PDT (Photodynamic Therapy), is now
SEOUL, South Korea, BUSAN, South Korea and SAN FRANCISCO, July 10, 2014 /PRNewswire/ -- SillaJen, Inc., a privately-held biotherapeutics company focused on the development of
In a surprising discovery, researchers have noticed that the same kinds of drugs that relive watery eyes and runny noses from allergies can also help fight off tumors. This new report suggests that antihistamines could have significant anti-cancer properties.
A new approach demonstrated that the recognition of unique cancer mutations appeared to be responsible for complete cancer regressions in two metastatic melanoma patients treated with a type of immunotherapy called adoptive T-cell therapy.
For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival.
OAKLAND, Calif., June 27, 2014 /PRNewswire/ -- When friends asked Warren Keppler what he wanted out of fatherhood back in 2004, his answer came naturally: "I want to run with my girls."
Immunitor Inc., reported that company’s first proof-of-concept clinical study of its candidate cancer vaccine in patients with terminal stage of liver cancer has been presented at the immunology
LONDON, June 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- The act of sweetening by admixture of some saccharine substance.
More Images (3 images) »